KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 123 filers reported holding KALA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $23,253,000 | -0.6% | 3,450,000 | 0.0% | 0.34% | -3.9% |
| Q4 2020 | $23,391,000 | -9.6% | 3,450,000 | 0.0% | 0.36% | -29.2% |
| Q3 2020 | $25,875,000 | -28.6% | 3,450,000 | 0.0% | 0.51% | -35.7% |
| Q2 2020 | $36,259,000 | +39.7% | 3,450,000 | +16.8% | 0.79% | -6.3% |
| Q1 2020 | $25,956,000 | +1794.6% | 2,952,899 | +4821.5% | 0.84% | +978.2% |
| Q3 2017 | $1,370,000 | – | 60,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,890,913 | $43,188,000 | 37.13% |
| CAXTON CORP | 544,220 | $12,430,000 | 12.65% |
| Vivo Capital, LLC | 1,158,911 | $26,470,000 | 5.35% |
| RA Capital Management | 2,113,236 | $48,266,000 | 4.36% |
| Orbimed Advisors | 2,375,279 | $54,251,000 | 0.52% |
| EAM Investors, LLC | 59,218 | $1,353,000 | 0.18% |
| Crestline Management, LP | 38,884 | $888,000 | 0.12% |
| OXFORD ASSET MANAGEMENT LLP | 192,426 | $4,374,000 | 0.08% |
| Eventide Asset Management | 60,000 | $1,370,000 | 0.08% |
| VICTORY CAPITAL MANAGEMENT INC | 543,525 | $12,414,000 | 0.03% |